PharmaCyte Biotech develops cancer cell therapies using its Cell-in-a-Box encapsulation technology, based in Las Vegas. PMCB reports earnings on Wed, Dec 16, 2026.
Earnings
Earnings calendar →Seasonality
How PMCB has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2013.
Whale Options Flow
90DNo whale options trades in PMCB in the last 90 days.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether PMCB is in one of them and how their past PMCB trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered PMCB in an article yet. Here's the latest on the wider market.
About PharmaCyte Biotech
PharmaCyte Biotech is a biotechnology company based in Las Vegas, Nevada, that develops cell therapies for cancer. Its Cell-in-a-Box technology places genetically engineered live human cells inside small capsules made mostly of cellulose, which are positioned near a tumor. Its main product candidate, CypCaps, is being developed for patients with locally advanced pancreatic cancer. Spending on these development programs has been reduced while the company reviews them.
- Headquarters
- Las Vegas, NV